Back To Top

No posts were found for provided query parameters.

Get Every Newsletter

Default title

image
April 28, 2025

XRP Soars with $30 Million Traded in Just 30 Minutes

XRP has demonstrated remarkable movement recently, rising over 6% in the last 24 hours and currently trading at $2.33. After weeks trapped in a narrow

image
April 28, 2025

Alphabet Beats Q1 Expectations While Investing Heavily in AI Amid

Alphabet Inc. (NASDAQ: GOOGL) experienced a surge in its stock price last Friday after releasing first-quarter results that exceeded expectations. The company reported a substantial

image
April 28, 2025

Market Insights: Earnings Season Sparks Excitement with Meta as a

Victoria Greene from G Squared Private Wealth shares her insights on the expected flood of earnings reports this week. With excitement surrounding corporate earnings, Greene

image
April 28, 2025

SEC’s Approval of XRP Futures ETFs Sparks Institutional Interest

The U.S. SEC has greenlit ProShares’ XRP Futures ETFs, catalyzing a wave of institutional interest in XRP. This regulatory approval could mark a turning point

image
April 28, 2025

Walmart’s E-Commerce Expansion: Can It Compete with Amazon?

A recent analysis by Bernstein explores the ongoing competition between Walmart (NYSE: WMT) and Amazon (NASDAQ: AMZN) in the e-commerce sector. The report compares both

image
April 28, 2025

Wells Fargo’s Paul Christopher Discusses Policy Movements Impacting Markets

Paul Christopher, head of global investment strategy at Wells Fargo Investment Institute, joins ‘Squawk Box’ to explore current market trends and outlooks. His discussion touches

image
April 28, 2025

Ethereum Navigates Key Threshold: Can It Hit $2K?

Ethereum has surged impressively, approaching a critical resistance level around $1.8K, although it is showing signs of losing momentum. Despite the recent increase, there exists

image
April 28, 2025

Galloway Capital Partners Advocates for WW International to Avoid Bankruptcy

WW International Inc. (NASDAQ: WW) is under significant pressure as it navigates over $1.6 billion in debt, amid increasing competition from weight-loss drugs like Ozempic.

PARTNERSHIPS

Read about us and our reason for existing

About Entreprenerdly

PARTNERSHIPS

PARTNERSHIPS